New York, February 11, 2026, 07:04 EST — Premarket
- Kenvue gained 0.9% to $18.32 before the market opened; Kimberly-Clark rose 1.1%
- According to SEC Form 4, Kenvue’s chief people officer automatically exercised expiring stock options, with shares withheld to cover taxes and fees
- Traders are focused on the delayed U.S. jobs report set for 8:30 a.m. ET, along with Kenvue’s results from February 17
Kenvue shares ticked up 0.9% to $18.32 in premarket trading Wednesday, tracking gains in potential acquirer Kimberly-Clark, which added 1.1% to $105.88. Investors awaited key U.S. economic data scheduled for later in the morning.
The key issue here is the connection between the two companies. Kenvue, spun off from Johnson & Johnson’s consumer-health division, has agreed to be acquired by Kimberly-Clark, the maker of Kleenex, in a deal involving both cash and stock. This structure means Kenvue’s shares will now fluctuate alongside Kimberly-Clark’s. According to the terms revealed in November, Kenvue shareholders will get $3.50 in cash plus 0.15 Kimberly-Clark shares for every Kenvue share they own. 1
Based on current prices, the package values Kenvue at about $19.38 per share, roughly $1.06 shy of the headline figure. That difference accounts for the time needed to close and the risks involved. Shareholders from both companies gave the green light to the deal in late January. The companies now expect the transaction to wrap up in the second half of 2026, pending regulatory approval and other conditions. 2
Kenvue has a near-term catalyst unrelated to the merger spread. The company plans to release its fourth-quarter and full-year 2025 results after the market closes on Feb. 17. However, it will skip the usual quarterly conference call while the Kimberly-Clark deal remains pending. 3
A recent Form 4 filing reveals that Kenvue Chief People Officer Luani Alvarado exercised 85,534 stock options at $13.76 each on Feb. 6. To cover the exercise price and taxes, Kenvue withheld 71,581 shares at $18.13. The filing also noted that no market transactions took place. 4
Kenvue’s board has declared a quarterly cash dividend of $0.2075 per share, set to be paid on Feb. 25. Shareholders on record as of the close of business Feb. 11 will be eligible, the company confirmed. 5
Beyond the deal, macro data could take center stage later this morning. The delayed U.S. payrolls report is set for 8:30 a.m. ET, with economists forecasting a 70,000 increase in January jobs and the unemployment rate holding at 4.4%, per a Reuters preview. The Labor Department’s calendar also shows January CPI is scheduled for release on Friday. 6
The risk hasn’t vanished despite the shareholder votes wrapping up. Proxy advisor ISS noted last month that “on balance, support for the transaction is warranted,” yet flagged the negative market response and ongoing litigation concerns linked to Kenvue products. 7
Traders are focused on the gap between Kenvue’s stock and the implied offer value, which fluctuates as Kimberly-Clark’s share price moves. If the regulatory timeline starts to slip, that’s where the first indicators will appear.
